246 related articles for article (PubMed ID: 21566112)
1. Familial C3 glomerulopathy associated with CFHR5 mutations: clinical characteristics of 91 patients in 16 pedigrees.
Athanasiou Y; Voskarides K; Gale DP; Damianou L; Patsias C; Zavros M; Maxwell PH; Cook HT; Demosthenous P; Hadjisavvas A; Kyriacou K; Zouvani I; Pierides A; Deltas C
Clin J Am Soc Nephrol; 2011 Jun; 6(6):1436-46. PubMed ID: 21566112
[TBL] [Abstract][Full Text] [Related]
2. Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis.
Gale DP; de Jorge EG; Cook HT; Martinez-Barricarte R; Hadjisavvas A; McLean AG; Pusey CD; Pierides A; Kyriacou K; Athanasiou Y; Voskarides K; Deltas C; Palmer A; Frémeaux-Bacchi V; de Cordoba SR; Maxwell PH; Pickering MC
Lancet; 2010 Sep; 376(9743):794-801. PubMed ID: 20800271
[TBL] [Abstract][Full Text] [Related]
3. C3 glomerulonephritis/CFHR5 nephropathy is an endemic disease in Cyprus: clinical and molecular findings in 21 families.
Deltas C; Gale D; Cook T; Voskarides K; Athanasiou Y; Pierides A
Adv Exp Med Biol; 2013; 735():189-96. PubMed ID: 23402027
[TBL] [Abstract][Full Text] [Related]
4. C3 glomerulopathy: clinicopathologic features and predictors of outcome.
Medjeral-Thomas NR; O'Shaughnessy MM; O'Regan JA; Traynor C; Flanagan M; Wong L; Teoh CW; Awan A; Waldron M; Cairns T; O'Kelly P; Dorman AM; Pickering MC; Conlon PJ; Cook HT
Clin J Am Soc Nephrol; 2014 Jan; 9(1):46-53. PubMed ID: 24178974
[TBL] [Abstract][Full Text] [Related]
5. Recurrence of complement factor H-related protein 5 nephropathy in a renal transplant.
Vernon KA; Gale DP; de Jorge EG; McLean AG; Galliford J; Pierides A; Maxwell PH; Taube D; Pickering MC; Cook HT
Am J Transplant; 2011 Jan; 11(1):152-5. PubMed ID: 21114651
[TBL] [Abstract][Full Text] [Related]
6. Clinical course and outcome after kidney transplantation in patients with C3 glomerulonephritis due to CFHR5 nephropathy.
Frangou E; Varnavidou-Nicolaidou A; Petousis P; Soloukides A; Theophanous E; Savva I; Michael N; Toumasi E; Georgiou D; Stylianou G; Mean R; Anastasiadou N; Athanasiou Y; Zavros M; Kyriacou K; Deltas C; Hadjianastassiou V
Nephrol Dial Transplant; 2019 Oct; 34(10):1780-1788. PubMed ID: 30844074
[TBL] [Abstract][Full Text] [Related]
7. C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up.
Sethi S; Fervenza FC; Zhang Y; Zand L; Vrana JA; Nasr SH; Theis JD; Dogan A; Smith RJ
Kidney Int; 2012 Aug; 82(4):465-73. PubMed ID: 22673887
[TBL] [Abstract][Full Text] [Related]
8. Evidence that NPHS2-R229Q predisposes to proteinuria and renal failure in familial hematuria.
Voskarides K; Arsali M; Athanasiou Y; Elia A; Pierides A; Deltas C
Pediatr Nephrol; 2012 Apr; 27(4):675-9. PubMed ID: 22228437
[TBL] [Abstract][Full Text] [Related]
9. Clinico-pathologic spectrum of C3 glomerulopathy-an Indian experience.
Viswanathan GK; Nada R; Kumar A; Ramachandran R; Rayat CS; Jha V; Sakhuja V; Joshi K
Diagn Pathol; 2015 Mar; 10():6. PubMed ID: 25889427
[TBL] [Abstract][Full Text] [Related]
10. Clinico-pathological correlations in 127 patients in 11 large pedigrees, segregating one of three heterozygous mutations in the COL4A3/ COL4A4 genes associated with familial haematuria and significant late progression to proteinuria and chronic kidney disease from focal segmental glomerulosclerosis.
Pierides A; Voskarides K; Athanasiou Y; Ioannou K; Damianou L; Arsali M; Zavros M; Pierides M; Vargemezis V; Patsias C; Zouvani I; Elia A; Kyriacou K; Deltas C
Nephrol Dial Transplant; 2009 Sep; 24(9):2721-9. PubMed ID: 19357112
[TBL] [Abstract][Full Text] [Related]
11. A novel CFHR5 fusion protein causes C3 glomerulopathy in a family without Cypriot ancestry.
Medjeral-Thomas N; Malik TH; Patel MP; Toth T; Cook HT; Tomson C; Pickering MC
Kidney Int; 2014 Apr; 85(4):933-7. PubMed ID: 24067434
[TBL] [Abstract][Full Text] [Related]
12. Molecular genetics of familial hematuric diseases.
Deltas C; Pierides A; Voskarides K
Nephrol Dial Transplant; 2013 Dec; 28(12):2946-60. PubMed ID: 24046192
[TBL] [Abstract][Full Text] [Related]
13. C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy.
Bomback AS; Santoriello D; Avasare RS; Regunathan-Shenk R; Canetta PA; Ahn W; Radhakrishnan J; Marasa M; Rosenstiel PE; Herlitz LC; Markowitz GS; D'Agati VD; Appel GB
Kidney Int; 2018 Apr; 93(4):977-985. PubMed ID: 29310824
[TBL] [Abstract][Full Text] [Related]
14. Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies.
Servais A; Noël LH; Roumenina LT; Le Quintrec M; Ngo S; Dragon-Durey MA; Macher MA; Zuber J; Karras A; Provot F; Moulin B; Grünfeld JP; Niaudet P; Lesavre P; Frémeaux-Bacchi V
Kidney Int; 2012 Aug; 82(4):454-64. PubMed ID: 22456601
[TBL] [Abstract][Full Text] [Related]
15. A large family with a gain-of-function mutation of complement C3 predisposing to atypical hemolytic uremic syndrome, microhematuria, hypertension and chronic renal failure.
Lhotta K; Janecke AR; Scheiring J; Petzlberger B; Giner T; Fally V; Würzner R; Zimmerhackl LB; Mayer G; Fremeaux-Bacchi V
Clin J Am Soc Nephrol; 2009 Aug; 4(8):1356-62. PubMed ID: 19590060
[TBL] [Abstract][Full Text] [Related]
16. C3 Glomerulopathy: Ten Years' Experience at Mayo Clinic.
Ravindran A; Fervenza FC; Smith RJH; De Vriese AS; Sethi S
Mayo Clin Proc; 2018 Aug; 93(8):991-1008. PubMed ID: 30077216
[TBL] [Abstract][Full Text] [Related]
17. A novel CFHR1-CFHR5 hybrid leads to a familial dominant C3 glomerulopathy.
Togarsimalemath SK; Sethi SK; Duggal R; Le Quintrec M; Jha P; Daniel R; Gonnet F; Bansal S; Roumenina LT; Fremeaux-Bacchi V; Kher V; Dragon-Durey MA
Kidney Int; 2017 Oct; 92(4):876-887. PubMed ID: 28729035
[TBL] [Abstract][Full Text] [Related]
18. A novel CFHR5 mutation associated with C3 glomerulonephritis in a Turkish girl.
Besbas N; Gulhan B; Gucer S; Korkmaz E; Ozaltin F
J Nephrol; 2014 Aug; 27(4):457-60. PubMed ID: 24536001
[TBL] [Abstract][Full Text] [Related]
19. FHR-5 Serum Levels and
Garam N; Cserhalmi M; Prohászka Z; Szilágyi Á; Veszeli N; Szabó E; Uzonyi B; Iliás A; Aigner C; Schmidt A; Gaggl M; Sunder-Plassmann G; Bajcsi D; Brunner J; Dumfarth A; Cejka D; Flaschberger S; Flögelova H; Haris Á; Hartmann Á; Heilos A; Mueller T; Rusai K; Arbeiter K; Hofer J; Jakab D; Sinkó M; Szigeti E; Bereczki C; Janko V; Kelen K; Reusz GS; Szabó AJ; Klenk N; Kóbor K; Kojc N; Knechtelsdorfer M; Laganovic M; Lungu AC; Meglic A; Rus R; Kersnik Levart T; Macioniene E; Miglinas M; Pawłowska A; Stompór T; Podracka L; Rudnicki M; Mayer G; Rysava R; Reiterova J; Saraga M; Seeman T; Zieg J; Sládková E; Stajic N; Szabó T; Capitanescu A; Stancu S; Tisljar M; Galesic K; Tislér A; Vainumäe I; Windpessl M; Zaoral T; Zlatanova G; Józsi M; Csuka D
Front Immunol; 2021; 12():720183. PubMed ID: 34566977
[TBL] [Abstract][Full Text] [Related]
20. Hereditary glomerulonephritis of non-Alport type.
Doherty CC; Middleton DT; Hill CM
Proc Eur Dial Transplant Assoc; 1983; 19():575-81. PubMed ID: 6878256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
